Form 4: Galecto Inc. Executive Garrett Winslow Reports Stock Option Grant
SEC Form 4 Filing
Garrett Winslow, General Counsel of Galecto, Inc., reports the acquisition of stock options.
Summary
- On October 9, 2024, Garrett Winslow, General Counsel of Galecto, Inc., was granted stock options to purchase 15,600 shares of common stock.
- The exercise price of the options is $7.49 per share.
- The options vest in 48 equal monthly installments over four years from the award date, contingent upon continued service.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard executive compensation disclosure.
Positives
- The granting of stock options to a key executive like the General Counsel can be seen as an incentive to align their interests with the long-term success of the company.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with shareholder value.
Stakeholder Impact
- The granting of stock options can potentially impact shareholders by diluting equity if the options are exercised.
Key Dates
| Date | Description |
|---|---|
| 10/09/2024 | Date of the stock option grant. |
| 10/09/2034 | Expiration date of the stock options. |
| 10/11/2024 | Date of signature on the Form 4 filing. |
Keywords
stock options, Form 4, Galecto, insider trading, executive compensation, GLTO, Garrett Winslow
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.